The present invention has been made to improve the requirements for realizing the commercialized "Personal Map-Based Customized Medicine Platform" based precision medicine. The present invention is directed to improving the precision and recall or reproducibility of personal genomes. It is designed to increase the method and to use the common GWAS (genome wide association study) marker to perform genotyping-based patient stratification, and to improve and improve the problem in linkage with Mach Supercombe developed by Korea Electronics and Telecommunications Research Institute. will be. In addition, research results for the improvement of commercialization of personal genetic map-based customized medical platform for use as customized medical and diagnostic device including reporting database analysis module that can be easily provided to multiple users in genomic big data and supercom environment. to be. When the technology is commercialized, most countries' genomic data-based customized medicine will remain in Academia, and in the case of only partially available reality, a customized medical platform can be provided that can be used in the first whole area.
展开▼
